Literature DB >> 10229996

Anticoagulant treatment of patients with atrial fibrillation in primary health care.

M Viitaniemi1, K Eskola, H Kurunmäki, A Latva-Nevala, A M Wallin, M Paloneva, I Virjo, S Ylinen, S Ohman, M Isokoski.   

Abstract

OBJECTIVE: To determine the prevalence of anticoagulant (AC) treatment of patients with atrial fibrillation in primary health care. To identify complications in the same patients during 1 year.
DESIGN: Cross-sectional study and 1-year follow-up.
SETTING: Seven health centres with a total population of 164093.
SUBJECTS: Five hundred and twenty-two anticoagulated patients with atrial fibrillation.
RESULTS: The age-adjusted prevalence of AC treated patients with atrial fibrillation was 0.30%. Of the 522 patients, 240 were men, mean age 69.6 years; and 282 women, mean age 75.1 years. At the beginning of the study 85% and after 1 year 81% of the latest prothrombin time values were within recommended range. After 1 year 414 out of the 522 patients continued AC treatment. During the 1-year follow-up 62 patients had minor or major complications. Eleven patients (2.1%) had to discontinue AC treatment because of complications. Prothrombin tests were mainly taken at 3-4 week intervals.
CONCLUSION: High quality AC treatment is possible in the hands of general practitioners.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229996     DOI: 10.1080/028134399750002926

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  3 in total

1.  The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study.

Authors:  Chris Burton; Chris Isles; John Norrie; Ruth Hanson; Elaine Grubb
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

2.  Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland.

Authors:  Irma Virjo; Kari Mäkelä; Juhani Aho; Pentti Kalliola; Harri Kurunmäki; Leena Uusitalo; Markku Valli; Suvi Ylinen
Journal:  Scand J Prim Health Care       Date:  2010-09-07       Impact factor: 2.581

3.  Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.

Authors:  Gunnar H Nilsson; Ingela Björholt
Journal:  BMC Clin Pharmacol       Date:  2004-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.